MADISON, WI, May 20, 2020 – A Madison-based collaboration has joined the fight to develop antibodies to combat COVID-19. Scientists at AdvantiGen Biosciences (Madison WI) and Dr. David Andes’ laboratory at the University of Wisconsin-Madison are teaming up to develop novel monoclonal antibodies (mAbs) against the SARS-CoV-2 virus that causes COVID-19.